Send the following on WhatsApp
Continue to Chat對抗變種新冠病毒:Pfizer/BioNTech 疫苗產生中和抗體、Qiagen 篩檢靈敏度不受影響 https://geneonline.news/bnt162b2-elicits-antibodies-neutralize-covid-19-pseudovirus/
對抗變種新冠病毒:Pfizer/BioNTech 疫苗產生中和抗體、Qiagen 篩檢靈敏度不受影響 https://geneonline.news/bnt162b2-elicits-antibodies-neutralize-covid-19-pseudovirus/